Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?

2010 ◽  
Vol 31 (3) ◽  
pp. 377-385 ◽  
Author(s):  
José T. Stefano ◽  
Claudia P. M. S. de Oliveira ◽  
Maria L. Corrêa-Giannella ◽  
Iberê C. Soares ◽  
Marcia S. Kubrusly ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Disease Progression ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Potential Marker ◽  
Liver Disease Progression ◽  
Alcoholic Fatty Liver Disease

scholarly journals Non-alcoholic fatty liver disease progression and current research

2019 ◽  
Vol 6 (1) ◽  
pp. 189-198
Author(s):  
Smriti Narayan ◽  
Sonu Kumar Gupta ◽  
Priyanka Singh ◽  
Villayat Ali ◽  
Malkhey Verma
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Disease Progression ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Liver Disease Progression ◽  
Alcoholic Fatty Liver Disease

scholarly journals Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes

2016 ◽  
Vol 4 (2) ◽  
pp. 183-187 ◽  
Author(s):  
TSUYOSHI MASHITANI ◽  
RYUICHI NOGUCHI ◽  
YASUSHI OKURA ◽  
TADASHI NAMISAKI ◽  
AKIRA MITORO ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Liver Disease ◽  
Fatty Liver ◽  
Disease Progression ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Liver Disease Progression ◽  
Alcoholic Fatty Liver Disease
Sign in / Sign up

Export Citation Format

Share Document